Effects of carvedilol on an ischemia/reperfusion model: Biochemical, histopathological and immunohistochemical evaluation

Journal of Obstetrics and Gynaecology Research

Volumn 42, Issue 9, 2016, Pages 1132-1140

  Özsoy, Asker Zeki ^a   Nursal, Ayşe Feyda ^b   Arıcı, Akgül ^a   Bütün, İlknur ^a   Uysal, Murat ^a   Irmak Sapmaz, Hilal ^a   Kunt İşgüder, Çiğdem ^a   Yılmaz Doğru, Hatice ^a   Taş, Ufuk ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

Author keywords

Carvediol; ischemia reperfusion injury; ovarian torsion; rat model

Indexed keywords

CARVEDILOL; CASPASE 3; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROTEIN BAX; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; CELL DEATH; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARIAN ISCHEMIA REPERFUSION INJURY; OVARIAN TISSUE; OVARY DISEASE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; TISSUE INJURY; TUNEL ASSAY;

EID: 84985916213     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.13028     Document Type: Article

References (44)

1. Bharathan R, Ramsawak L, Kelly A. Ovarian torsion: Opportunities to improve clinical management. J Obstet Gynaecol 2012; 32: 683–686.
2. Sahin FK, Cosar E, Koken G, Toy H, Basarali K, Buyukbas S. Protective effect of aprotinin on ischemia–reperfusion injury in rat ovary. J Obstet Gynaecol Res 2008; 34: 794–800.
3. Becker JH, de Graaff J, Vos MC. Torsion of the ovary: A known but frequently missed diagnosis. Eur J Emerg Med 2009; 16: 124–126.
4. Somuncu S, Cakmak M, Dikmen G, Akman H, Kaya M. Ischemia–reperfusion injury of rabbit ovary and protective effect of trapidil: An experimental study. Pediatr Surg Int 2008; 24: 315–318.
5. Borekci B, Gundogdu C, Altunkaynak BZ et al. The protective effect of dehydroepiandrosterone on ovarian tissues after torsion-detorsion injury: A stereological and histopathological study. Eurasian J Med 2009; 41: 22–27.
6. Frishman WH. Carvedilol. N Engl J Med 1998; 339: 1759–1765.
7. Oliveira PJ, Bjork JA, Santos MS et al. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 2004; 200: 159–168.
8. Book WM. Carvedilol: A nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 2002; 8: 173–177.
9. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 1996; 17: 24–29.
10. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–421.
11. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–169.
12. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497–500.
13. Tas U, Cayli S, İnanır A et al. Aquaporin-1 and aquaporin-3 expressions in the intervertebral disc of rats with aging. Balkan Med J 2012; 29: 349–353.
14. Ingec M, Isaoglu U, Yilmaz M et al. Prevention of ischemia–reperfusion injury in rat ovarian tissue with the on–off method. J Physiol Pharmacol 2011; 62: 575–582.
15. Oelsner G, Bider D, Goldenberg M, Admon D, Mashiach S. Long-term follow-up of the twisted ischemic adnexa managed by detorsion. Fertil Steril 1993; 60: 976–979.
16. Lass A. The fertility potential of women with a single ovary. Hum Reprod Update 1999; 5: 546–550.
17. Celik H, Ayar A, Tug N et al. Effects of melatonin on noncardiogenic pulmonary edema secondary to adnexial ischemia–reperfusion in guinea pig. Neuro Endocrinol Lett 2002; 23: 115–118.
18. Taşkın O, Birincioğlu M, Aydın A et al. The effects of twisted ischaemic adnexa managed by detorsion on ovarian viability and histology: An ischaemia-reperfusion rodent model. Hum Reprod 1998; 13: 2823–2875.
19. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227–C241.
20. Chaves R, Cruz ME, Dominquez R. Differences in the ovulation rate of the right or left ovary in unilaterally ovariectomized rats. Effects of ipsi- and contralateral vagus nerves on remaining ovary. J Endocrinol 1987; 113: 397–400.
21. Coleman DA, Fleming MW, Dailey RA. Factors effecting ovarian compensation after unilateral ovariectomy in gilts. J Anim Sci 1984; 59: 170–176.
22. Cakmak M, Kaya M, Barlas M et al. Histologic and ultrastructural changes in the contralateral ovary in unilateral ovarian torsion: An experimental study in rabbits. Tokai J Exp Clin Med 1993; 18: 167–178.
23. Akgur FM, Kilinc K, Tanyel FC, Buyukpamukcu N, Hicsonmez A. Ipsilateral and contralateral testicular biochemical acute changes after unilateral testicular torsion and distorsion. Urology 1994; 44: 413–418.
24. York JP, Drago JR. Torsion and the contralateral testicle. J Urol 1985; 133: 294–297.
25. Sade M, Amato S, Buyuksu C, Mertan S, Canda MS, Kaplanoglu N. The effect of testicular torsion on the contralateral testis and the value of various types of treatment. Br J Urol 1988; 62: 69–71.
26. Caglayan EK, Caglayan K, Göcmen AY et al. Protective effect of ethyl pyruvate on ischemia–reperfusion injury in rat ovary: Biochemical and histopathological evaluation. Eur J Obstet Gynecol Reprod Biol 2014; 182: 154–159.
27. Celik M, Aksoy AN, Aksoy H, Aksoy Y, Halici Z. Sildenafil reduces ischemia–reperfusion injury in rat ovary: Biochemical and histopathological evaluation. Gynecol Obstet Invest 2014; 78: 162–167.
28. Yapca OE, Turan MI, Borekci B, Akcay F, Suleyman H. Bilateral ovarian ischemia/reperfusion injury and treatment options in rats with an induced model of diabetes. Iran J Basic Med Sci 2014; 17: 294–302.
29. Ergenoglu M, Erbaş O, Akdemir A et al. Attenuation of ischemia/reperfusion-induced ovarian damage in rats: Does edaravone offer protection. Eur Surg Res 2013; 51: 21–32.
30. Sengul O, Ferah I, Polat B et al. Blockade of endothelin receptors with bosentan limits ischaemia/reperfusion-induced injury in rat ovaries. Eur J Obstet Gynecol Reprod Biol 2013; 170: 458–463.
31. Akbas H, Ozden M, Kanko M et al. Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury. J Int Med Res 2005; 33: 528–536.
32. Parlaktas BS, Atilgan D, Gencten Y et al. The effects of carvedilol on ischemia–reperfusion injury in the rat testis. Int Braz J Urol 2014; 40: 109–117.
33. Yasar A, Erdemir F, Parlaktas BS et al. The effect of carvedilol on serum and tissue oxidative stress parameters in partial ureteral obstruction induced rat model. Kaohsiung J Med Sci 2013; 29: 19–25.
34. Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 2007; 25: 731–741.
35. Ronsein GE, Guidi DB, Benassi JC, Filho DW, Pedrosa RC, Pedrosa RC. Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver. Redox Rep 2005; 10: 131–137.
36. Huang H, Shan J, Pan XH, Wang HP, Qian LB, Xia Q. Carvedilol improved diabetic rat cardiac function depending on antioxidant ability. Diabetes Res Clin Pract 2007; 75: 7–13.
37. Rodrigues MA, Rodrigues JL, Martins NM et al. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem Biol Interact 2011; 189: 45–51.
38. Ozyigit MT, Turkaslan T, Ertugrul O, Ertugrul BM, Cevikbas U, Ozsoy Z. Protective effects of carvedilol on ischemia–reperfusion injury in rat epigastric island skin flap. Eur J Plast Surg 2007; 30: 129–136.
39. Ma XL, Yue TL, Lopez BL et al. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia–reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther 1996; 277: 128–136.
40. Singh D, Chander V, Chopra K. Carvedilol attenuates ischemia–reperfusion-induced oxidative renal injury in rats. Fundam Clin Pharmacol 2004; 18: 627–634.
41. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 1998; 24: 869–875.
42. Romeo F, Li D, Shi M, Mehta JL. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: Modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res 2000; 45: 788–794.
43. Spallarossa P, Garibaldi S, Altieri P et al. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 2004; 37: 837–846.
44. Zeng H, Liu X, Zhao H. Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia–reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 127–130.